Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Lei Cui
Trillium Therapeutics Inc,
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
21
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Targeting Cd47-Sirpa Axis Shows Potent Preclinical Anti-Tumor Activity as Monotherapy and Synergizes With Parp Inhibition
Number of pages: 35
Posted: 17 Oct 2022
Hussein Al-Sudani
,
Ying Ni
,
Philip Jones
,
Huseyin Karakilic
, Lei Cui,
Lisa D.S. Johnson
,
Peter G. Rose
,
Alexander Olawaiye
,
Robert P. Edwards
,
Robert A. Uger
,
Gloria Lin
and
Haider Mahdi
Einstein Medical Center Montgomery - Internal Medicine Department, Cleveland Clinic - Center for Immunotherapy & Precision Immuno-Oncology, University of Pittsburgh - Magee-Women's Research Institute, University of Pittsburgh - Magee-Women's Research Institute, Trillium Therapeutics Inc,, Trillium Therapeutics Inc,, Cleveland Clinic - Division of Gynecologic Cancer, University of Pittsburgh - Magee-Women's Research Institute, University of Pittsburgh - Magee-Women's Research Institute, Trillium Therapeutics Inc,, Trillium Therapeutics Inc, and University of Pittsburgh - Magee-Women's Research Institute
Downloads
21
(1,436,435)
View PDF
Download
Abstract:
Feedback
